APA (7th ed.) Citation

COLEMAN, C. I., WEEDA, E. R., KHARAT, A. A., BOOKHART, B., & BAKER, W. L. (2019). 1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria. Diabetes (New York, N.Y.), 68(Supplement_1), . https://doi.org/10.2337/db19-1150-P

Chicago Style (17th ed.) Citation

COLEMAN, CRAIG I., ERIN R. WEEDA, AKSHAY A. KHARAT, BRAHIM BOOKHART, and WILLIAM L. BAKER. "1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria." Diabetes (New York, N.Y.) 68, no. Supplement_1 (2019). https://doi.org/10.2337/db19-1150-P.

MLA (9th ed.) Citation

COLEMAN, CRAIG I., et al. "1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria." Diabetes (New York, N.Y.), vol. 68, no. Supplement_1, 2019, https://doi.org/10.2337/db19-1150-P.